Most dermal fillers used in the United States are temporary. Hyaluronic acid (HA) fillers such as Juvéderm and Restylane last six months to two years and can be dissolved with an enzyme called hyaluronidase if a complication develops. Biostimulators such as Sculptra (poly-L-lactic acid) and Radiesse (calcium hydroxylapatite) stimulate the body's own collagen and then are gradually absorbed.
Bellafill is different. It is the only FDA-approved permanent dermal filler sold in the US. Its active ingredient — polymethylmethacrylate (PMMA) microspheres — does not dissolve. Once injected, the microspheres remain in the tissue indefinitely as a scaffold around which the body lays down its own collagen. There is no enzyme that can remove them. If a nodule, granuloma, or misplaced injection appears months or years later, the options are surgical excision or living with it — not a dissolving injection.
That permanence is the single most important fact about Bellafill, and it shapes everything else about who is and is not a candidate.
What Bellafill is made of
Bellafill is a biphasic filler: roughly 20% non-resorbable PMMA microspheres suspended in 80% carrier gel. The carrier is mostly water with 3.5% bovine (cow-derived) collagen, 0.3% lidocaine, and buffers. Each prefilled syringe contains 0.8 mL of product, and the PMMA microspheres are sized at 30 to 50 microns — large enough to avoid being engulfed by immune cells, which is part of how the manufacturer intends them to sit inertly in tissue.
The mechanism is two-phase. The bovine collagen gel provides immediate volume the day it is injected. Over the following weeks to months, the body metabolizes that collagen. As it disappears, the PMMA microspheres stay behind and act as a scaffold around which the patient's own collagen forms, producing the longer-term correction.
What it is FDA-approved for
Bellafill carries two FDA-approved indications, both under Premarket Approval (PMA) supplement P020012/S009:
- Nasolabial folds ("smile lines") — approved in 2006 (originally under the name ArteFill), with manufacturer-supported data extending through five years.
- Moderate to severe, atrophic, distensible facial acne scars on the cheek — approved January 6, 2015, in patients over 21. Bellafill is the only dermal filler with an FDA-approved indication for acne scars.
Everything else — tear troughs, marionette lines, chin or cheek augmentation, jawline, temples, hands — is off-label use. Off-label does not mean illegal, and providers may use FDA-approved devices off-label within their judgment. It does mean that for those areas the safety and effectiveness data supporting the specific injection is thinner, and the permanence tradeoff is harder to justify in zones where complications are harder to treat.
The two gating issues every patient should understand
1. Bovine collagen allergy — a required skin test
Because the carrier gel contains bovine collagen, Bellafill can trigger allergic reactions in people sensitized to bovine protein. A skin test is required before treatment. In the original US clinical trial, roughly 1.7% of tested subjects had a positive skin test and were excluded from treatment. Contraindications include a positive skin test, a known bovine collagen allergy, lidocaine allergy, a history of severe allergies, and patients undergoing desensitization injections to meat products (which can contain bovine collagen). The skin test is not a formality — it changes who can safely receive the product.
2. Permanence and the absence of a dissolver
This is the property that most separates Bellafill from every HA filler. If an HA filler is placed poorly, migrates, or causes a vascular problem, hyaluronidase can dissolve it within hours. There is no equivalent for PMMA. Late complications — nodules, granulomas, or palpable lumps — can appear months or years after injection. Management typically involves intralesional steroids, antibiotics if infection is suspected, and in cases that do not resolve, surgical removal. Removal of a permanent filler from the face is not a minor procedure.
Who is not a candidate
Because the material cannot be removed, patient selection matters more with Bellafill than with any temporary filler. Contraindications and poor-fit scenarios include:
- Positive Bellafill skin test or known bovine collagen allergy — absolute contraindication.
- Keloid formers or a history of hypertrophic scarring — the PMMA scaffold and the body's collagen response can drive excessive scar formation.
- Lip augmentation — Bellafill is specifically contraindicated for injection into the lips or vermilion; the mobile, vascular lip is a high-risk zone where permanent material and nodule risk are difficult to manage.
- Thin skin — PMMA microspheres can become visible or palpable ("beading") under thin skin, which is why Bellafill is best suited to deeper, well-defined folds in patients with relatively thick overlying skin.
- Bleeding disorders — listed contraindication.
- Pregnancy, breastfeeding, and patients under 21 — safety has not been established; Bellafill is not studied or indicated in these groups.
- Patients who want reversibility or a "try it first" option — a permanent filler is the wrong product for anyone uncertain about whether they will like the result.
How Bellafill compares to other fillers
| Property | HA fillers (Juvéderm, Restylane) | Biostimulators (Sculptra, Radiesse) | Bellafill (PMMA) |
|---|---|---|---|
| Duration | 6–24 months | 12–24+ months (collagen) | Permanent (manufacturer data through 5 years for folds) |
| Reversible | Yes — hyaluronidase | No (resorbs over time) | No (does not resorb) |
| Onset | Immediate | Gradual over weeks–months | Immediate (collagen carrier), then sustained |
| Allergy testing | Not required | Not required | Required (bovine collagen skin test) |
| FDA-approved areas | Many facial areas (varies by product) | Specific facial areas (varies by product) | Nasolabial folds; cheek acne scars |
The tradeoff Bellafill offers is durability for reversibility. For a patient with deep, stable nasolabial folds and thick skin who is a good skin-test candidate and who understands the permanence, that tradeoff can be reasonable. For a patient who values the ability to reverse a result — or who is treating an area where nodules would be difficult to manage — an HA filler is the safer default.
What it costs
Bellafill is more expensive per syringe than a typical HA filler. Reported prices cluster around $800 to $1,000+ per 0.8 mL syringe. The American Society of Plastic Surgeons does not publish a Bellafill-specific average; it groups the product within its "non-hyaluronic acid filler" category (alongside Radiesse, Sculptra, and Renuva), whose national average surgeon/physician fee was about $901 per syringe in 2023. A nasolabial-fold treatment commonly uses one to two syringes; acne-scar correction often requires several syringes depending on scar number and severity, so a single treatment session can run from roughly $800 into the low thousands.
The value argument Bellafill makes is durability: if a correction holds for five years rather than the six to eighteen months typical of an HA filler, the cumulative cost of repeated syringes may be lower over time. That math only holds for a well-selected patient who is happy with the result — and because the filler is permanent, a result the patient dislikes is also durable. Cost is one more reason the decision before injection matters: a reversible HA filler that disappoints is a few hundred dollars and a hyaluronidase appointment; a permanent filler that disappoints is a much harder problem to undo.
What the evidence does and does not show
Bellafill's manufacturer cites the longest-running dermal filler study in support of the nasolabial-fold indication, with safety data extending through 12 years, and the acne-scar approval was supported by a controlled trial. Independent dermatology literature has also documented late granulomatous reactions to PMMA, sometimes years after injection and sometimes triggered by events such as infection or trauma. Both things are true: the material is durable and manufacturer-supported studies report long-term safety, and the same durability means that when complications occur, they are persistent and difficult to treat. Bellafill has not been studied in ice-pick acne scars or sinus tracts, and the acne-scar indication is specifically for atrophic, distensible scars on the cheek.
What to ask your provider
- Is the area I want treated an FDA-approved indication for Bellafill, or is this off-label use? If off-label, ask why a permanent filler is preferred over a reversible option.
- When will the skin test be done, and how long before treatment? A negative skin test is a prerequisite, not an optional step.
- What is the plan if a nodule or granuloma develops months or years from now? A provider experienced with Bellafill should have a clear answer about intralesional steroids, follow-up, and surgical backup.
- How many Bellafill treatments has this provider performed, specifically in this anatomic area? Permanence rewards experience and penalizes inexperience more than any temporary filler does.
- Am I a candidate for a reversible HA filler or a resorbable biostimulator instead? If the answer does not include a fair comparison, get a second opinion.
Bellafill occupies a narrow but real niche: a permanent correction for the right patient, in the right area, with the right provider. Its risk profile is manageable when those three conditions are met and unforgiving when they are not. The decision to use a non-removable filler is one of the few in aesthetic medicine where the patient cannot simply change their mind later — which is exactly why the conversation before injection matters more than the injection itself.
Sources
- FDA Instructions for Use, Bellafill (P020012/S009) — composition, indications, contraindications: https://www.accessdata.fda.gov/cdrh_docs/pdf2/P020012S009c.pdf
- ASDS patient information: Injectable Polymethylmethacrylate + Bovine Collagen Filler (Bellafill): https://www.asds.net/skin-experts/skin-treatments/injectables/injectable-polymethylmethacrylate-bovine-collagen-filler
- FDA aesthetic and cosmetic devices — dermal fillers (soft tissue fillers): https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers
- Bellafill (Tiger Aesthetics) — approved indications and patient information: https://bellafill.com/for-physicians
- Background and basic science of polymethylmethacrylate fillers (peer-reviewed review): https://www.rejuvenationresource.com/articles/background-science/background-basic-science-of-polymethylmethacrylate-fillers
- Drugs.com: Bellafill uses, side effects, and warnings: https://www.drugs.com/bellafill.html
- American Society of Plastic Surgeons — average surgeon/physician fee for non-hyaluronic-acid dermal fillers (cost reference; includes Bellafill): https://www.plasticsurgery.org/cosmetic-procedures/dermal-fillers/cost
